141 related articles for article (PubMed ID: 32664067)
1. Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report.
Hui Y; Wang J; Han J; Guo Z; Sun S; Wu Z; Wang Y; Han Z; Chen X
Medicine (Baltimore); 2020 Jul; 99(28):e20727. PubMed ID: 32664067
[TBL] [Abstract][Full Text] [Related]
2. Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
Wang Y; Bi M; Zhang H; Gao Z; Zhou H; Chang S
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e528-e530. PubMed ID: 28028915
[TBL] [Abstract][Full Text] [Related]
3. Concurrent apatinib and local radiation therapy for advanced gastric cancer: A case report and review of the literature.
Zhang M; Deng W; Cao X; Shi X; Zhao H; Duan Z; Lv B; Liu B
Medicine (Baltimore); 2017 Mar; 96(9):e6241. PubMed ID: 28248891
[TBL] [Abstract][Full Text] [Related]
4. The safety of apatinib for the treatment of gastric cancer.
Geng R; Song L; Li J; Zhao L
Expert Opin Drug Saf; 2018 Nov; 17(11):1145-1150. PubMed ID: 30324820
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Li J; Qin S; Xu J; Xiong J; Wu C; Bai Y; Liu W; Tong J; Liu Y; Xu R; Wang Z; Wang Q; Ouyang X; Yang Y; Ba Y; Liang J; Lin X; Luo D; Zheng R; Wang X; Sun G; Wang L; Zheng L; Guo H; Wu J; Xu N; Yang J; Zhang H; Cheng Y; Wang N; Chen L; Fan Z; Sun P; Yu H
J Clin Oncol; 2016 May; 34(13):1448-54. PubMed ID: 26884585
[TBL] [Abstract][Full Text] [Related]
6. S-1 plus apatinib as first-line palliative treatment for stage IVB gastroesophageal junction adenocarcinoma: A case report and review of the literature.
Zhang C; Yu GM; Zhang M; Liu D
Medicine (Baltimore); 2020 Jan; 99(1):e18691. PubMed ID: 31895837
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
Chen H; Xue L; Liu L; Li P
J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of apatinib combined with or without chemotherapy for patients with advanced or metastatic chemotherapy-refractory gastric adenocarcinoma: A prospective clinical study.
Guo Y; Tang J; Huang XE; Cao J
Medicine (Baltimore); 2019 Feb; 98(6):e13908. PubMed ID: 30732125
[TBL] [Abstract][Full Text] [Related]
9. [Safety and short-term efficacy of apatinib combined with oxaliplatin and S-1 in the conversion treatment for gastric cancer with peritoneal metastasis].
Ye ZS; Zeng Y; Wei SH; Wang Y; Chen S; Lin ZT; Wang ZW; Chen XL; Chen LC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):240-247. PubMed ID: 34645168
[No Abstract] [Full Text] [Related]
10. Apatinib for the treatment of gastric cancer.
Geng R; Li J
Expert Opin Pharmacother; 2015 Jan; 16(1):117-22. PubMed ID: 25420417
[TBL] [Abstract][Full Text] [Related]
11. Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status.
Chen J; Wang J; Miao Q
Medicine (Baltimore); 2019 Nov; 98(45):e17890. PubMed ID: 31702665
[TBL] [Abstract][Full Text] [Related]
12. A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer.
Li XF; Tan YN; Cao Y; Xu JH; Zheng S; Yuan Y
Medicine (Baltimore); 2015 Sep; 94(39):e1661. PubMed ID: 26426663
[TBL] [Abstract][Full Text] [Related]
13. Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report.
Zhao C; Zhang Q; Qiao W
Medicine (Baltimore); 2017 Dec; 96(50):e9276. PubMed ID: 29390380
[TBL] [Abstract][Full Text] [Related]
14. The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature.
Ding L; Li QJ; You KY; Jiang ZM; Yao HR
Medicine (Baltimore); 2016 May; 95(20):e3598. PubMed ID: 27196461
[TBL] [Abstract][Full Text] [Related]
15. Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.
Scott LJ
Drugs; 2018 May; 78(7):747-758. PubMed ID: 29663291
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy and safety of apatinib treatment in advanced gastric cancer.
Yang Y; Wu X; Li F; Wang N; Zhang M; Sun T; Chen Z
J Cancer Res Ther; 2019; 15(2):365-369. PubMed ID: 30964112
[TBL] [Abstract][Full Text] [Related]
17. Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report.
Liu J; Zheng Y; Xu N
Medicine (Baltimore); 2019 Feb; 98(5):e14328. PubMed ID: 30702616
[TBL] [Abstract][Full Text] [Related]
18. A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
Zhu XR; Zhu ML; Wang Q; Xue WJ; Wang YW; Wang RF; Chen SY; Zheng LZ
Medicine (Baltimore); 2016 Sep; 95(37):e4610. PubMed ID: 27631210
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.
Zhao J; Zhang X; Gong C; Zhang J
Medicine (Baltimore); 2017 Dec; 96(50):e9259. PubMed ID: 29390367
[TBL] [Abstract][Full Text] [Related]
20. Apatinib-induced hyperammonemic encephalopathy.
Liu Y; Chen X; Gao X; Chen JX; Chen J
J Oncol Pharm Pract; 2020 Mar; 26(2):465-470. PubMed ID: 31068089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]